acetazolamide has been researched along with Hypergammaglobulinemia in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Hypergammaglobulinemia: An excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The course was complicated by superior sagittal sinus thrombosis which we believe to be related to acetazolamide therapy." | 3.66 | Benign intracranial hypertension, monoclonal gammopathy, and superior sagittal sinus thrombosis. ( Davis, CE; Gilman, JK; Hibri, N; Smith, CH, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilman, JK | 1 |
| Smith, CH | 1 |
| Davis, CE | 1 |
| Hibri, N | 1 |
| Leys, A | 1 |
| Vandenberghe, P | 1 |
2 other studies available for acetazolamide and Hypergammaglobulinemia
| Article | Year |
|---|---|
Benign intracranial hypertension, monoclonal gammopathy, and superior sagittal sinus thrombosis.
Topics: Acetazolamide; Arm; Cranial Sinuses; Humans; Hypergammaglobulinemia; Immunoglobulin G; Leg; Male; Mi | 1983 |
Serous macular detachments in a patient with IgM paraproteinemia: an optical coherence tomography study.
Topics: Acetazolamide; Aged; Diabetes Mellitus, Type 2; Diagnostic Techniques, Ophthalmological; Fluorescein | 2001 |